KAREN A MIOTTO

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports
    Karen Miotto
    David Geffen School of Medicine at UCLA, Semel Institute of Neuroscience and Human Behavior, 760 Westwood Plaza, Los Angeles, CA 90095, United States
    Drug Alcohol Depend 132:1-12. 2013
  2. pmc Comparison of buprenorphine treatment for opioid dependence in 3 settings
    Karen Miotto
    Department of Psychiatry, University of California at Los Angeles, CA, USA
    J Addict Med 6:68-76. 2012
  3. doi request reprint Managing co-occurring substance use and pain disorders
    Karen Miotto
    Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA 90095 1563, USA
    Psychiatr Clin North Am 35:393-409. 2012
  4. ncbi request reprint Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal
    K Miotto
    UCLA Dept of Psychiatry and Biobehavioral Sciences, 760 Westwood Plaza, Los Angeles, CA 90024, USA
    Am J Addict 10:232-41. 2001
  5. ncbi request reprint Naltrexone and dysphoria: fact or myth?
    Karen Miotto
    UCLA Department of Psychiatry and Biobehavioral Sciences, 90024, USA
    Am J Addict 11:151-60. 2002
  6. pmc Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions
    Wendy M Walwyn
    Shirley and Stephan Hatos Center for Neuropharmacology, Semel Institute, Los Angeles, CA 90024 1759, USA
    Drug Alcohol Depend 108:156-65. 2010
  7. ncbi request reprint Precipitated opioid withdrawal across acute physical dependence induction methods
    Peggy Compton
    School of Nursing, University of California at Los Angeles, Los Angeles, CA 90266, USA
    Pharmacol Biochem Behav 77:263-8. 2004
  8. ncbi request reprint Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers
    Edythe D London
    Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, University of California Los Angeles, 760 Westwood Plaza, PO Box 175919, Los Angeles, CA 90024 1759, USA
    Arch Gen Psychiatry 61:73-84. 2004
  9. ncbi request reprint Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics
    Lara A Ray
    Department of Psychology, University of California Los Angeles, CA 90095 1563, USA
    CNS Neurol Disord Drug Targets 9:13-22. 2010
  10. ncbi request reprint A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals
    Richard A Rawson
    UCLA Integrated Substance Abuse Programs, Los Angeles, CA 90025, USA
    Addiction 101:267-74. 2006

Research Grants

  1. GHB: Effects, Withdrawal and Treatment
    Karen Miotto; Fiscal Year: 2006

Detail Information

Publications11

  1. doi request reprint Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports
    Karen Miotto
    David Geffen School of Medicine at UCLA, Semel Institute of Neuroscience and Human Behavior, 760 Westwood Plaza, Los Angeles, CA 90095, United States
    Drug Alcohol Depend 132:1-12. 2013
    ....
  2. pmc Comparison of buprenorphine treatment for opioid dependence in 3 settings
    Karen Miotto
    Department of Psychiatry, University of California at Los Angeles, CA, USA
    J Addict Med 6:68-76. 2012
    ..Although use of buprenorphine in the treatment of opioid dependence is expected to continue to increase, little is known about the optimal setting for providing the medical and psychosocial care required with buprenorphine pharmacotherapy...
  3. doi request reprint Managing co-occurring substance use and pain disorders
    Karen Miotto
    Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA 90095 1563, USA
    Psychiatr Clin North Am 35:393-409. 2012
    ..The optimal ingredients for safe opioid treatment include a strong provider-patient relationship and clinician training in the assessment and treatment of addiction and pain...
  4. ncbi request reprint Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal
    K Miotto
    UCLA Dept of Psychiatry and Biobehavioral Sciences, 760 Westwood Plaza, Los Angeles, CA 90024, USA
    Am J Addict 10:232-41. 2001
    ..Participants dependent on GHB reported using multiple daily doses around the clock. High frequency users appeared at the greatest risk for developing withdrawal delirium and psychosis after abrupt discontinuation of GHB use...
  5. ncbi request reprint Naltrexone and dysphoria: fact or myth?
    Karen Miotto
    UCLA Department of Psychiatry and Biobehavioral Sciences, 90024, USA
    Am J Addict 11:151-60. 2002
    ..These studies did not reveal dysphoria to be a serious side effect produced by naltrexone treatment. Additional studies to evaluate long-term endocrine effects and antidepressant combination therapy are warranted...
  6. pmc Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions
    Wendy M Walwyn
    Shirley and Stephan Hatos Center for Neuropharmacology, Semel Institute, Los Angeles, CA 90024 1759, USA
    Drug Alcohol Depend 108:156-65. 2010
    ....
  7. ncbi request reprint Precipitated opioid withdrawal across acute physical dependence induction methods
    Peggy Compton
    School of Nursing, University of California at Los Angeles, Los Angeles, CA 90266, USA
    Pharmacol Biochem Behav 77:263-8. 2004
    ..Thus, despite altering the pretreatment opioid and route of administration, all three APD protocols produced similar and reliable withdrawal symptoms in humans...
  8. ncbi request reprint Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers
    Edythe D London
    Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, University of California Los Angeles, 760 Westwood Plaza, PO Box 175919, Los Angeles, CA 90024 1759, USA
    Arch Gen Psychiatry 61:73-84. 2004
    ..Mood disturbances in methamphetamine (MA) abusers likely influence drug use, but the neurobiological bases for these problems are poorly understood...
  9. ncbi request reprint Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics
    Lara A Ray
    Department of Psychology, University of California Los Angeles, CA 90095 1563, USA
    CNS Neurol Disord Drug Targets 9:13-22. 2010
    ..Limitations and future directions in the research and practice of naltrexone for alcoholism are also outlined...
  10. ncbi request reprint A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals
    Richard A Rawson
    UCLA Integrated Substance Abuse Programs, Los Angeles, CA 90025, USA
    Addiction 101:267-74. 2006
    ..The present study sought to directly compare the effectiveness of (CM) and (CBT) alone and in combination in reducing stimulant use...
  11. ncbi request reprint The effects and consequences of selected club drugs
    Thomas E Freese
    UCLA Integrated Substance Abuse Programs, 11050 Santa Monica Boulevard, Suite 100, Los Angeles, CA 90025, USA
    J Subst Abuse Treat 23:151-6. 2002
    ..Medical visits for club drug-related toxicity have sharply increased across the country. This article provides a brief review of the literature on club drugs...

Research Grants1

  1. GHB: Effects, Withdrawal and Treatment
    Karen Miotto; Fiscal Year: 2006
    ..There has been little systematic study of the signs and symptoms of withdrawal, and controlled studies on the effectiveness of treatment of these symptoms are lacking. ..